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Review
The Breast Cancer and the Environment 
Research Centers (BCERC) sponsored by 
the National Institute for Environmental 
Health Sciences (NIEHS) and the National 
Cancer Institute (NCI) were established to 
better understand how environmental factors 
may influence pubertal development and to 
enable primary breast cancer prevention strat­
egies. In 2003, after a period of focused and 
thoughtful advocacy integrated with scientific 
consultation, BCERCs were awarded to The 
Fox Chase Comprehensive Cancer Center 
in Philadelphia, Pennsylvania; Michigan 
State University in East Lansing, Michigan; 
the University of Cincinnati, Ohio; and the 
University of California San Francisco Helen 
Diller Family Comprehensive Cancer Center.
In this review, we define the BCERC 
research questions and present our common 
conceptual framework for the etiology of 
breast cancer and the rationale for a focus on 
puberty. Then, across multiple levels of bio­
logic, behavioral, and social organization, we 
highlight our current scientific understand­
ing of the development of the normal mam­
mary gland, the nature and action of breast 
cancer risk factors, and our understanding 
of the mechanisms of breast carcinogenesis 
relevant to early development. Our BCERC 
experimental approach is driven by the knowl­
edge gaps in this understanding. We con­
clude with a description of the organization of 
the BCERC.
Research Questions
We explore whether exposures to environmen­
tal factors (e.g., phenols, phthalates, phyto­
estrogens, genistein, dietary fat, ionizing 
radiation, psychosocial factors) before and dur­
ing puberty might set the stage for increased 
breast cancer risk in adulthood. Multiple 
hypotheses are being tested by developing and 
interrogating rodent models and rodent and 
human cell culture systems to characterize the 
molecular basis of mammary gland develop­
ment over the life span. We seek to deter­
mine how environmental agents may affect 
this development and to better understand the 
process of breast carcinogenesis. In simultane­
ously conducted epidemiologic cohort studies 
of prepubertal girls, conceptually integrated 
with the studies in animal and human tissue 
models, additional hypotheses posit roles for 
the environmental, psychological, behavioral, 
metabolic, and genetic factors as determinants 
of puberty. This transdisciplinary approach will 
generate information about relevant exposures 
from human studies that can be applied to the 
animal studies. In turn, the animal studies will 
provide a mechanistic understanding of how 
environmental exposures may affect pubertal 
breast development and adversely influence 
breast cancer risk in adult life.
This research adds to the findings of other 
similar research relevant to breast cancer, early 
development, and the environment, includ­
ing the National Growth and Health Study 
(Braithwaite et al. 2009), the Child Health 
and Development Study (Cohn et al. 2003), 
the CHAMACOS (Center for the Health 
Assessment of Mothers and Children of 
Salinas) cohort study (Eskenazi et al. 1999), 
the Fels Longitudinal Study (Demerath 
et al. 2007), the Bogalusa Heart Study 
(Freedman et al. 2002), and the ALSPAC 
(Avon Longitudinal Study of Pregnancy and 
Childhood) study in England (Golding 1990), 
as well as other longitudinal early development 
studies around the world. The uniqueness of 
BCERC is the combination of its longitudinal 
design with questionnaire, biomarker data 
collected before puberty, the determination 
of pubertal maturation end points by physical 
examination, the focus on breast cancer etiol­
ogy, and the transdisciplinary integration of 
biologic laboratory­based science, epidemiol­
ogy, and community participation.
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oBjectives: We introduce and describe the Breast Cancer and the Environment Research Centers 
(BCERC), a research network with a transdisciplinary approach to elucidating the role of environ-
mental factors in pubertal development as a window on breast cancer etiology. We describe the 
organization of four national centers integrated into the BCERC network.
da t a s o u r c e s: Investigators use a common conceptual framework based on multiple levels of bio-
logic, behavioral, and social organization across the life span. The approach connects basic biologic 
studies with rodent models and tissue culture systems, a coordinated multicenter epidemiologic 
cohort study of prepubertal girls, and the integration of community members of breast cancer advo-
cates as key members of the research team to comprise the network.
da t a e x t r a c t i o n: Relevant literature is reviewed that describes current knowledge across levels 
of organization. Individual research questions and hypotheses in BCERC are driven by gaps in our 
knowledge that are presented at genetic, metabolic, cellular, individual, and environmental (physical 
and social) levels.
da t a synthesis: As data collection on the cohort, animal experiments, and analyses proceed, results 
will be synthesized through a transdisciplinary approach.
co n c l u s i o n: Center investigators are addressing a large number of specific research questions 
related to early pubertal onset, which is an established risk factor for breast cancer. BCERC research 
findings aimed at the primary prevention of breast cancer will be disseminated to the scientific 
community and to the public by breast cancer advocates, who have been integral members of the 
research process from its inception.
key w o r d s : breast cancer, cohort, environment, etiology, transdisciplinary science. Environ Health 
Perspect 117:1814–1822 (2009).  doi:10.1289/ehp.0800120 available via http://dx.doi.org/ [Online 
16 June 2009]Breast Cancer and the Environment Research Centers
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Methods
Conceptual Framework: Breast 
Development and Carcinogenesis 
across the Life Span
The BCERC initiative is multidisciplinary in 
its approach to research questions and in the 
integrated nature of the science with com­
munity and advocacy participation. Although 
not prescribed by the National Institutes of 
Health’s request for applications, investiga­
tors are invested in making our approach 
truly transdisciplinary (Rosenfield 1992). 
Transdisciplinary science occurs when scientists 
from multiple disciplines work inter  actively on 
a common problem with a common concep­
tual model (or framework) and, as a result, 
develop novel cross­disciplinary methods, 
insights, and research approaches that would 
not have occurred with a traditional unidisci­
plinary investigation. This approach is consis­
tent with the current movement toward team 
science and interdisciplinary research evidenced 
by recent reports and funding initiatives 
[Hiatt and Breen 2008; Stokols et al. 2003; 
Transdisciplinary Research on Energetics and 
Cancer (TREC) 2008].
BCERC investigators have agreed on a 
common conceptual framework that acknowl­
edges the complexity of breast cancer etiologic 
factors along a life span continuum from pre­
natal in utero exposures through puberty and 
maturity to the postmenopausal years. Our 
framework permits multiple investigators to 
locate their particular hypotheses within the 
framework, taking into account our best under­
standing of pubertal development and the envi­
ronment from both a socioecological and life 
span perspective (Smedley and Syme 2001).
At each stage of the life span, the frame­
work recognizes possible influences at mul­
tiple levels from genes to cells, tissues, and 
the organism, through individual behavior, 
to family, neighborhood, and other upstream 
social factors.
Although the focus in our study of humans 
is limited to the prepubertal and pubertal 
stages of the life span, our animal models 
allow us to consider the mechanistic basis for 
the effects of environmental exposures on the 
mammary gland across the life span. This in 
turn will provide a bridge for the development 
and testing of mechanism­based prevention 
strategies in humans.
Rationale for Focus on Puberty
The onset of puberty in girls is defined clini­
cally by the first signs of breast develop­
ment, pubic hair, and other secondary sex 
characteris  tics (Grumbach and Styne 2002). 
The rationale for our focus on puberty stems 
from the well­established observation that a 
later onset of menarche is associated with a 
decreased risk of breast cancer in adult life 
(Kelsey and Bernstein 1996). The magnitude 
of the decreased risk is in the range of 9% 
and 4% for each additional year of menarche 
delay for pre­ and postmenopausal women, 
respectively (Clavel­Chapelon 2002; Hsieh 
et al. 1990). The risk for breast cancer among 
those with an earlier age of menarche is 1.2–
2.2 times greater when contrasted with those 
with later age of menarche (Garland et al. 
1998; Titus­Ernstoff et al. 1998).
The onset of menarche has been used in 
studies of adult women as a marker of puber­
tal onset, but the relationship between the 
onset of puberty and menarche has not been 
constant over secular time (Euling et al. 
2008). In the United States, the correlation 
between onset of puberty and menarche was 
> 0.9 for women born in the 1930s, 0.5–0.7 
for those born in the 1950s, and 0.38–0.39 
for those born in the 1970s (Biro et al. 2006). 
To complicate matters further, a longitudi­
nal study that followed girls annually noted 
that development of either primary breast 
areolar or pubic hair, usually breast, lagged 
behind maturation of the other factor in more 
than half the cohort (asynchronous matura­
tion) (Biro et al. 2003). These results need 
to be confirmed in other longitudinal studies 
(Euling et al. 2008) but suggest that factors 
contributing to onset of puberty and menar­
che were more similar in the past than in 
more recent years, and the clear differentia­
tion is needed between their time of onset and 
the duration between them (tempo). 
It is also well established that both the age 
at which girls begin puberty and their age of 
menarche have declined over the last century 
(Euling et al. 2008). This strongly suggests 
that changes in lifestyle and/or environmental 
factors have influenced these trends. Early 
development is considered an adverse effect 
because of its impact on outcomes in adoles­
cence, such as accelerated skeletal maturation 
and short adult height, unwanted pregnancies, 
sexually transmitted infections, and psycho­
social difficulties, and because of its potential 
impact on adult diseases such as breast can­
cer and elements of the metabolic syndrome 
(Golub et al. 2008).
When menarche is accelerated with­
out a concomitant acceleration in the tim­
ing of menopause, it is widely thought that 
the increased duration of hormone exposure 
over a lifetime promotes the development of 
breast cancer (de Waard and Thijssen 2005). 
However, it may be that the pubertal transi­
tion itself is critical because of rapid breast 
development and the susceptibility of rap­
idly duplicating cells to environmental insults 
(Berkey et al. 1999). Compared with other 
times in life, the pubertal breast in the rodent 
contains the highest number and the greatest 
proliferative activity of the terminal duct lobu­
lar units (TDLUs), the functional units of the 
breast (Rudland 1993). This may be related 
to the apparent susceptibility of the breast 
to   carcinogens during puberty (Colditz and 
Frazier 1995; Knight and Sorensen 2001).
Thus, puberty is a critical period during 
which to assess the impact of exposures to 
endocrine disruptors in the environment that 
interfere with normal hormonal synthesis and 
metabolic pathways, such as agents in the 
families of phenols, phthalates, and phyto­
estrogens (Buck Louis et al. 2008). Endocrine 
disruptors found in the environment may 
influence both the timing and pace of the 
pubertal transition as well as female repro­
ductive outcomes and early­life development 
(Crain et al. 2008). It is also likely that consti­
tutional factors play a role in age at puberty, 
and that genetic variability in pathways that 
influence maturation, such as hormonal and 
growth factors, may affect onset of puberty 
and menses. The effects of environmental 
exposures or lifestyle factors may be most pro­
nounced among those whose genetic or other 
biologic characteristics make them most sus­
ceptible to mediating pathways (Freedman 
et al. 2002; Pathak et al. 2000).
Gaps in Knowledge and the BCERC 
Experimental Approach
Two major hypotheses are being investigated 
by BCERC: First is that puberty is a window 
of biological susceptibility to carcinogenesis; 
second is that the advent of puberty initiates 
a window of hormonal stimulation ending in 
menopause. These are not mutually exclusive, 
and some environmental agents may perturb 
both. The focus of the biologic studies is on 
the characteristics of breast development in 
normal and cancer­prone rodent models, as 
well as the influence of environmental factors 
on breast development and breast carcinogen­
esis. The focus of the epidemiologic studies is 
on the elucidation of multiple determinants 
of early puberty with data collected longi­
tudinally over a 5­year period to encompass 
the first signs of pubertal maturation. The 
cohort is composed of 1,222 girls recruited 
with mean ages at baseline of 7.13 years in 
Cincinnati, 7.34 years in New York City, and 
7.38 years in the San Francisco Bay Area. A 
parent or guardian identified 34.4% of the 
girls as white non­Hispanic; 25.3% as black 
non­Hispanic; 4.3% as black Hispanic; 29.9% 
as Hispanic; 4.5% as Asian; and 1.7% in some 
other category. Integrated into the structure of 
the BCERCs are four Community Outreach 
and Translational Cores (COTCs) that are 
participants in the research studies and whose 
members work to translate the current scien­
tific knowledge, as well as findings from new 
research, into educational messages for the 
community. Simultaneously, they provide 
input from the community perspective into 
the ongoing research of the BCERCs.Hiatt et al.
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In utero and prepubertal phases. Although 
past studies of the association between birth 
weight and breast cancer risk have yielded 
inconsistent results, recent meta­analyses have 
demonstrated an increased risk with larger 
birth weights (Park et al. 2008; Xue and 
Michels 2007). This suggests that the in utero 
hormonal milieu may influence breast cancer 
risk. Trichopoulos and others have hypoth­
esized that higher levels of hormones during 
pregnancy favor the generation of a higher 
number of susceptible stem cells with com­
promised genomic stability (Trichopoulos 
et al. 2005). Others have posited that in utero 
exposures to estrogens, androgens, insulin­like 
growth factor 1 (IGF­1), and possibly alpha­
fetoprotein might be associated with increased 
breast cancer risk (Ekbom et al. 1997; Forman 
et al. 2005).
In animal models, in utero stem cells in 
the fetal breast are capable of cancer initiation, 
and this may be true in humans as well (Russo 
and Russo 1996). The presence of a popula­
tion of stem cells in the fetal breast and their 
continued presence in the adult reproductive 
years has been demonstrated in rodent mod­
els (Chepko and Smith 1999). The cyclical 
epithelial proliferation in the breast associated 
with ovulatory menstrual cycles, as well as the 
breast’s ability to repopulate itself with each 
pregnancy is also consistent with the presence 
of human mammary stem cells (Stingl et al. 
2006). These cells, under the influence of hor­
mones and growth factors, may be directly 
involved in carcinogenesis (Wicha 2008). 
BCERC investigators are exploring the loca­
tion and function of stem cells in the mam­
malian breast to elucidate their possible role 
in   carcinogenesis.
At birth, the breast consists of a rudimen­
tary ductal system. The degree of develop­
ment at birth is attributable to the influence 
of maternal hormones (Anbazhagan et al. 
1991). By 2 years of age, the breast undergoes 
involution and is composed of a primitive 
ductal system without alveoli (Howard and 
Gusterson 2000). BCERC investigators are 
seeking a more detailed understanding of the 
nature of normal mammary development in 
animal models to provide insights into nor­
mal breast development and breast carcino­
genesis in humans.
Puberty. Until the onset of puberty, the 
breast remains in a dormant state. At puberty 
the exact mechanisms responsible for breast 
development have not been defined, but the 
initiation of puberty in girls is coincident 
with the activation of the hypothalamic–
pituitary–gonadal (HPG) axis, or thelarche, 
and the activation of the hypothalamic– 
pituitary–adrenal (HPA) axis, or adrenarche, 
which are independent events. A surge of 
pituitary follicle­stimulating hormone (FSH), 
associated with HP axis activation, stimulates 
primordial ovarian follicles to secrete estro­
gen. Circulating estrogen in turn induces 
mammary duct, mammary stromal connec­
tive tissue, pituitary luteinizing hormone 
(LH), and vascular proliferation and growth 
(Rogol 1998). The ratio of FSH to LH favors 
FSH at the onset of puberty, and even with 
the onset of menarche, ovarian function con­
tinues to be anovulatory (MacMahon et al. 
1982b). The activation of the HPA axis stim­
ulates the adrenal production of dehydro  epi­
androsterone, dehydroepiandrosterone sulfate, 
and androstenedione, which lead to the devel­
opment of secondary sexual characteristics 
including pubic hair, acne, and body odor. 
The relative timing of thelarche and adrenar­
che may differentially determine the onset 
of menarche (Biro et al. 2006). The dura­
tion of anovulatory menstrual cycles after the 
onset of menarche varies from 1 to > 6 years, 
with longer intervals to ovulation in women 
with a late menarche (Clavel­Chapelon 2002; 
MacMahon et al. 1982a). The shorter the 
period of anovulation, the higher the breast 
cancer risk (Henderson et al. 1981).
The manifestation of breast development 
that we are studying in the epidemiologic 
project is assumed to reflect the underlying 
mammary biology studied in rodent models in 
the biology project. In rodent models, we are 
characterizing the rate of development, extent, 
and character of the mammary epi  thelium. 
With improved animal models and biomark­
ers to study the impact of environmental stres­
sors on breast cancer, we can elucidate the 
effects of the timing of these exposures during 
critical windows of vulnerability.
Focusing now on the phase of pubertal 
development, we describe factors of influ­
ence at multiple levels of organization, start­
ing with genes and concluding with the social 
environment.
Genes. Relatively little is known about 
how genetic makeup influences breast cancer 
risk at the time of puberty. It is unclear, for 
example whether BRCA mutations interact 
with environmental factor to increase risk 
(Chang­Claude et al. 2007; Kotsopoulos et al. 
2007). Mutations and polymorphisms in 
genes that control the synthesis and metabo­
lism of hormones or environmental toxicants 
that act as endocrine disruptors may, how­
ever, have some role in pubertal development.
It has been demonstrated, for example, 
that high­activity CYP3A4 (cytochrome P450 
3A4) alleles, which primarily metabolize tes­
tosterone, are associated with early puberty 
and are more common in African­American 
than Hispanic or white girls (Kadlubar et al. 
2003). There may also be important interac­
tions of these genes with body mass, such that 
girls with higher body mass indices (BMIs) 
are more likely to overexpress these genes 
and enter puberty at earlier ages. BCERC 
investigators are using new technologies to 
assess gene and protein expression to elucidate 
the effects of multiple genetic polymorphisms, 
including those affecting hormone synthesis 
and metabolism and carcinogen metabolism. 
As another example, leptin is important in 
normal regulation of childhood weight gain, 
maturation, and development of second­
ary sexual features. Leptin levels, which are 
thought to reflect body composition and are 
best predicted by BMI (Charmandari et al. 
2002), rise with age before puberty, suggest­
ing that a threshold effect may trigger puberty 
(Ong et al. 1999). Polymorphisms in the pro­
moter region of the leptin gene, which have 
been shown to affect tissue leptin secretion 
rates (Hoffstedt et al. 2002), could affect age 
at onset of puberty, particularly in relation to 
other factors such as BMI, diet, and physi­
cal activity. Although analysis of a large data 
set did not show associations between poly­
morphisms in the leptin receptor and BMI in 
adults (Heo et al. 2002), these variants could 
play a greater role in pubertal development.
Common variants in LH and FSH 
genes could also impact timing of puberty 
(Lamminen and Huhtaniemi 2001). The FSH 
receptor gene has two distinct isoforms, with 
ovarian response to FSH stimulation depen­
dent on the FSHR genotype (Perez Mayorga 
et al. 2000). FSH secretion is regulated partly 
by inhibin, and inhibin B levels correlate 
positively with age and FSH concentrations 
several years before the onset of puberty, with 
concomitant increases during breast develop­
ment (Crofton et al. 2002).
Genetic variability may also influence age 
at puberty indirectly, such as genetic predictors 
of body size. Furthermore, the potential effects 
of environmental exposures may be mediated 
by genetic differences in metabolic pathways. 
The effects of lifestyle factors, such as physical 
activity, on maturation could be influenced by 
constitutional factors. In the BCERC, we will 
investigate the role of genetic polymorphisms 
that may directly influence maturation or that 
may interact with environmental and lifestyle 
factors to impact age at puberty.
Metabolic pathways. The exact mecha­
nisms through which underlying hormon­
ally related risk factors work are not known 
(Aupperlee et al. 2005–2006; Clavel­
Chapelon 2002). However, the ovarian 
hormones, estrogen and progesterone, are 
believed to play an important role in the 
etiology of breast cancer (Henderson and 
Feigelson 2000). A recent systematic review 
found 15 prospective studies of endogenous 
hormones and breast cancer risk in postmeno­
pausal women that consistently showed that 
the highest quintile of estradiol and testoster­
one conferred an increased relative risk in the 
range of 2.0–2.2 compared with the lowest 
quintile (Cummings et al. 2009). In addition, Breast Cancer and the Environment Research Centers
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exogenous progestins, used in combina­
tion with estrogens in menopausal hormone 
replacement therapy (HRT), increase breast 
cancer risk, whereas estrogen­alone HRT is 
not associated with an increase (Greiser et al. 
2005; Rossouw et al. 2002). Thus, to achieve 
a better understanding of the mechanisms of 
progesterone action in the breast, BCERC 
investigators are using in vivo and in vitro 
mouse and rat mammary gland models to 
advance our understanding of the mechanisms 
of action of the two isoforms of progesterone, 
PR­A and PR­B, and their specific functions 
in normal mammary gland development dur­
ing puberty, at sexual maturity, during and 
after pregnancy, and after carcinogen expo­
sure in mammary cancer development.
There is also evidence that certain tran­
scription factors such as Stat5, Id2, and 
C/EBPβ are involved in alveologenesis and 
are effectors of progesterone and prolactin­
driven mammary gland development (Miyoshi 
et al. 2002; Seagroves et al. 1998). Beyond the 
potential for dysregulation by steroid disrup­
tors, Stat5 (Paukku and Silvennoinen 2004) 
and C/EBPβ (Ramji and Foka 2002) can also 
be activated by proinflammatory cytokines, 
thus presenting another avenue for environ­
mental influences on mammary gland develop­
ment being explored by BCERC scientists.
Cells and tissues. The cells in the TDLU 
of the human breast are at their peak of cell 
replication during puberty and through early 
adulthood. In animal studies, the susceptibil­
ity of the TDLU to neoplastic transforma­
tion has been confirmed by in vitro studies 
that have shown that this structure has the 
highest proliferative activity and rate of car­
cinogen binding to DNA. More important, 
when treated with carcinogens in vitro, the 
epithelial cells express phenotypes indicative 
of cell transformation (Russo et al. 1993). 
These studies indicate that, in the human 
breast, the target cell of carcinogens is found 
in a specific compartment whose characteris­
tics are the determining factors in initiation. 
These TDLU are believed to contain stem 
cells that will become the targets of the neo­
plastic event, depending on a) topographic 
location within the mammary gland tree, 
b) age at exposure to a known or putative 
genotoxic agent, and c) reproductive history 
of the host. Further, this structure has the 
highest proliferative activity, estrogen receptor 
(ER) content, and rate of carcinogen binding 
to DNA (Russo and Russo 2008).
Epidemiologic studies demonstrate that 
an early first pregnancy and an increase in 
parity are associated with a decrease in the 
risk of breast cancer, each additional live 
birth conferring a 10% risk reduction (Lambe 
et al. 1994). Several hypotheses have been 
put forth to explain the protective effect of 
early pregnancy: induction of differentiation, 
decreased proliferative activity, altered hor­
monal milieu, and alteration in cell fate 
(Sivaraman and Medina 2002). In both rats 
and mice, estrogen and progesterone, in the 
absence of pregnancy, can reproduce the 
protective effect. Induction of differentiation 
per se cannot explain the beneficial effect, as 
treatments with differentiation­inducing hor­
mones or drugs fail to confer the protective 
effect (Guzman et al. 1999). Likewise, it is 
unlikely that decreased proliferative activity or 
reduced cellular levels of ER and PR in parous 
animals can explain the protective effect of 
pregnancy (Kariagina et al. 2008; Sivaraman 
and Medina 2002). An alternative cell­fate 
hypothesis (Russo et al. 2008; Sivaraman and 
Medina 2002) proposes that the hormones 
of pregnancy induce a molecular switch in 
stem cells that produces cells with persistent 
changes in regulatory pathways that control 
proliferation and response to DNA damage. 
These cells may be able to metabolize carcino­
gens and repair DNA damage more efficiently 
than cells of the virginal gland and are thus 
less susceptible to carcinogenesis. The higher 
incidence of breast cancer observed in nul­
liparous women may be the result of the per­
sistence of unmodified stem cells.
Pregnancy also can confer an increased 
risk of breast cancer for a period of time after 
delivery (Pathak 2002). Postlactational invo­
lution has been shown to cause profound 
changes in the stromal environment. It has 
been hypothesized that this stromal environ­
ment change may favor the growth of incipi­
ent cancers and be the basis for increased risk 
of breast cancer after pregnancy (Schedin et al. 
2007). Understanding the basis of pregnancy­
induced protective and/or promotional effects 
may lead to the development of novel strate­
gies for the prevention of breast cancer.
Mammary epithelial development also 
depends on molecules produced by the 
stromal cells (Wiseman and Werb 2002), 
including fibroblasts, adipocytes (Iyengar et al. 
2003), macrophages, eosinophils (Gouon­
Evans et al. 2002), and mast cells. Molecules 
involved in the communication between the 
microenvironment and the epithelial cells 
include EGF, FGF2, FGF10, HGF, fibro­
blast secreted protein, transforming growth 
factor β (Bhowmick et al. 2004; Muraoka­
Cook et al. 2006), the chemokine CXCL­12, 
(stromal derived factor 1α), type I collagen 
(Ingman et al. 2006), matrix metalloprotei­
nase (MMP)­13, MMP­3, and MMP­14 
(membrane­type 1 MMP) (Page­McCaw 
et al. 2007; Sternlicht et al. 2006). Stromal 
cells also influence steroid hormone responses 
in the epithelium (Haslam and Woodward 
2003). Changes in these stromal cells as the 
result of environmental stressors may therefore 
not only perturb normal pubertal develop­
ment, but create a nurturing environment for 
a developing mammary neoplasm (Barcellos­
Hoff and Ravani 2000; Maffini et al. 2004).
The microenvironment can even prevent 
malignant cells from committing to neoplasia. 
Restoration of normal microenvironmental 
signaling can reverse the malignant phenotype 
even though the cancer cells retain all of their 
neoplastically transforming mutations (Bissell 
and Radisky 2001). In addition, although a 
normal stroma may protect the epithelium 
from tumorigenesis, an aberrant stroma can 
initiate tumorigenesis (Barcellos­Hoff and 
Ravani 2000; Bhowmick et al. 2004; Maffini 
et al. 2004). Alterations in stromal composi­ . Alterations in stromal composi­
tion can also alter steroid hormone responses 
in cancer cells and affect responses to endo­
crine therapies (Xie and Haslam 2008). These 
stromal cells appear to carry on many normal 
functions, but they drive transformation by 
hijacking normal cellular responses and induc­
ing them at the wrong place or at the wrong 
time (Jessani et al. 2004). Further elucidation 
of the interactions between the epithelial and 
stromal elements of the developing breast and 
the susceptibility of these interactions to envi­
ronmental factors is a key focus for BCERC 
investigators.
Individual behavior and psychosocial fac-
tors. Diet and the nutritional content of food 
consumed in the prepubertal years may be 
the key factor leading to prepubertal over­
weight and obesity, which is at the forefront 
of suspected contributors to early puberty 
(Kaplowitz 2008). Recent national surveil­
lance data show that 19% of U.S. children 
6–11 years of age are overweight as defined 
by being above the 95th percentile for their 
age in BMI (Ogden et al. 2006). Although 
studies have established that girls with higher 
BMIs are likely to experience puberty at an 
earlier age (Biro et al. 2003), the mechanisms 
by which this occurs and the determinants of 
prepubertal obesity are not well understood 
(Jasik and Lustig 2008).
Obesity during childhood may be asso­
ciated with increased risk of premenopausal 
breast cancer (Weiderpass et al. 2004). 
Obesity in the prepubertal period may also 
set the stage for the effects of overweight 
and obesity in later life. During adulthood, 
most data suggest that obesity is associated 
with increased risk of postmenopausal breast 
cancer, even though it is protective for pre­
menopausal breast cancer (Magnusson et al. 
2005; Verla­Tebit and Chang­Claude 2005). 
Obesity represents a constellation of physical 
attributes that include BMI and waist and 
hip circumference. This is relevant because in 
the New York University Women’s Health 
Study and the EPIC (European Prospective 
Investigation Into Cancer and Nutrition) 
Study, premenopausal breast cancer risk was 
inversely correlated with BMI; however, when 
adjusted for BMI, waist and hip circumference Hiatt et al.
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were associated with increased breast cancer 
risk (Sonnenschein et al. 1999). Mechanistic 
explanations as to how obesity may be pro­
tective in pre  menopausal women include 
decreased estrogen levels in obese women, who 
have anovulatory cycles (Pike et al. 1993), but 
the epidemiologic evidence to support this is 
inconsistent (Garland et al. 1998).
Overall caloric intake, the role of individ­
ual nutrients, and dietary intake of substances 
such as phytoestrogens may also play a role in 
pubertal development. For example, urinary 
concentrations of phytoestrogens, particularly 
daidzein and genistein, have been associated 
with later age of breast development in girls in 
New York City, and this protective effect was 
more pronounced in girls with lower BMIs 
(Wolff et al. 2008). Further investigation of 
the effects of these substances is another focus 
of BCERC investigators.
The impact of decreased physical activity 
independent of energy intake and its effects in 
different subgroups of children require further 
investigation. In the BCERC epidemiologic 
study, investigators are assessing dietary intake 
by 24­hr recalls administered to the primary 
caregiver at four times each year during the 
prepubertal baseline year. Likewise, detailed 
physical activity patterns are being assessed. 
Growth patterns are being closely monitored 
by annual or biannual assessments of height, 
weight, anthropometric measures, and body 
fat measurements.
Psychosocial factors are of interest because 
they have also been found to influence tim­
ing of puberty among girls (Bogaert 2005; 
Ellis and Garber 2000; Graber et al. 1997). 
Reproductive maturation appears to accelerate 
in stressful family contexts, characterized by 
low­quality parental investment, high levels of 
stress, negative relationships, and prolonged 
distress (Romans et al. 2003). In contrast, 
family relationships characterized by warmth, 
cohesion, and stability consistently appear 
to have a protective effect and predict later 
pubertal onset (Graber et al. 1995). Maternal 
depression, which is characterized by with­
drawal and lack of engagement, has also been 
linked to early maturation for female chil­
dren (Ellis and Garber 2000). The proposed 
mechanism through which acceleration likely 
occurs is via activation of the stress­mediating 
HP and sympathoadrenal systems (Grumbach 
and Styne 2002). Moreover, studies have 
linked absence of a biological father to early 
pubertal maturation and indicate that girls 
growing up in father­absent homes are about 
twice as likely to experience menarche before 
12 years of age (Mustanski et al. 2004; 
Quinlan 2003). A review of the father­absence 
literature suggests that menarche among girls 
in father­absent homes occurs 2–5 months 
earlier than in homes with father involvement 
(Ellis 2004), whereas mother absence does not 
appear to influence pubertal timing (Bogaert 
2005). Although more tenuous, childhood 
psychopathology may also be a significant risk 
factor for early puberty. A short­term lon­
gitudinal study (Hayward et al. 1997) indi­
cated that a cluster of internalizing symptoms, 
including depression, predicted advanced 
puberty among girls about 5 months earlier 
than their same­age peers, and increases in 
prepubertal anxiety have also predicted earlier 
pubertal onset, independent of family adver­
sity (Tremblay and Frigon 2005). 
In BCERC, to assess the importance of 
these and other psychological factors, stan­
dardized measures are being used longitudi­
nally to evaluate constructs, including child 
psychopathology [Behavior Assessment 
System for Children, Parent Report (Reynolds 
and Kamphaus 2002)], maternal depression 
[Center for Epidemiologic Studies Depression 
Scale (Radloff 1977)], family environment 
[Family Environment Scale (Moos 1990)], 
and in the Cincinnati Center only, child self­
reported depression [Childhood Depression 
Index (Kovacs 1992)].
Environment. Factors at the environmen­
tal level can influence pubertal development 
and ultimately breast cancer in three major 
ways: a) the physical environment—expo­
sure to environmental pollutants or toxicants; 
b) the built environment, which influences 
whether children have a healthy place to 
live, play, and go to school; and c) the social 
environment—the associations with socio­
economic status (SES) and race/ethnicity, 
social norms of behavior, and culture. These 
are contextual aspects of place as opposed to 
constitutive aspects, which are the sum of the 
individual characteristics of persons living in 
any particular geographically defined area.
The physical environment. The impact 
of putative environmental toxicants on breast 
development and carcinogenesis is at the heart 
of BCERC studies. A broad array of environ­
mental carcinogens is being evaluated in animal 
models and/or in the epidemiologic studies.
Xenoestrogens are part of a large group 
of synthetic and naturally occurring agents 
termed endocrine disruptors because of their 
capacity to perturb normal hormonal actions. 
It has been suggested that some endocrine dis­
ruptors may contribute to the development of 
hormone­dependent cancers (Sonnenschein 
and Soto 1998). One ubiquitous source of 
endocrine­disrupting chemicals is personal 
care products and cosmetics (Wolff et al. 
1996), which may include substances in the 
categories of parabens, phthalates, and organic 
solvents. Butyl benzyl phthalate (BBP) is an 
estrogenic compound and partial agonist for 
the ER (Zacharewski et al. 1998) widely used 
in plastic food wraps and other plastics, as well 
as in cosmetic formulations. Animal studies in 
rats have shown that prenatal exposure to 500 
or 1,000 mg/kg BBP or 250 or 375 mg/kg of 
its major metabolite, monobenzyl phthalate, 
induced significant alterations in the repro­
ductive system of male offspring, including 
undescended testes and decrease in the ano­
genital distance (Ema and Miyawaki 2002; 
Ema et al. 2003). Several in vitro tests have 
demonstrated the estrogenic activity of BBP 
(Hong et al. 2005; Zacharewski et al. 1998), 
but there is poor evidence on the mechanism 
mediating the effect of BBP on cell prolifera­
tion. It is likely that the estrogenic response is 
elicited not only via the ER, but also through 
the activation of other still­unknown path­
ways (Baker et al. 1999).
The widely used industrial monomer 
bisphenol A (BPA), another xenoestrogen, 
is polymerized in the manufacture of poly­
carbonate plastic and epoxy resins. Human 
exposure occurs by the leaching of BPA from 
plastic­lined food and beverage contain­
ers and from some dental sealants (Brotons 
et al. 1995; Olea et al. 1996), and the rate of 
leaching may greatly increase when the poly­
carbonate polymer is scratched and discolored 
(Howdeshell et al. 2003). BPA was found in 
95% of urinary samples tested in a large study 
in the United States (Calafat et al. 2005). 
Evidence for estrogenic effects of BPA has 
been reported in several studies showing that 
it activates ERα and ERβ (Matthews et al. 
2001; Routledge et al. 2000) and stimulates 
MCF­7 breast cancer cell growth (Krishnan 
et al. 1993). There is some uncertainty as 
to the level and risk of exposure to BPA in 
humans, but evidence suggests that it can dis­
rupt normal reproductive tract development 
in male and female rodents (Ramos et al. 
2001; Suzuki et al. 2002).
Persistent organic pollutants (POPs) are a 
class of chemicals that are lipophilic and resis­
tant to degradation and thus persist in the 
food chain and individual fat stores. POPs 
include chemicals such as aldrin, chlordane, 
DDT (dichlorodiphenyltrichloroethane), 
dieldrin, heptachlor, and polychlorinated 
biphenyls (PCBs), which have become highly 
prevalent in the environment of industrial­
ized countries since World War II. A study of 
brominated flame retardants (polybrominated 
biphenyls) among accidentally exposed farm 
workers in Michigan revealed an association 
with earlier pubic hair, but not breast develop­
ment, in the daughters of exposed mothers 
(Blanck et al. 2000). Polybrominated diphenyl 
ethers are a subgroup of flame retardants that 
are now being phased out because of proven 
toxicity, but a number are still in common use 
and are under study in relationship to pubertal 
development. Pesticides, which are ubiquitous 
in the environment and can be measured in 
biospecimens from all U.S. adults and chil­
dren, are POPs associated with earlier menar­
che in several (Gladen et al. 2000; Ouyang Breast Cancer and the Environment Research Centers
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et al. 2005; Vasiliu et al. 2004) but not all 
studies (Denham et al. 2005). A recent study 
made use of long­term human data and found 
that girls who had been exposed to DDT 
before 14 years of age had a higher incidence 
of breast cancer than those who had not been 
exposed (Cohn et al. 2007). PCBs have been 
inconsistently related to breast cancer in adult 
women in observational studies, but there is 
evidence from at least four studies of a gene–
environment interaction with CYP1A1 such 
that high levels of PCB exposure and expres­
sion of CYP1A1 confer a higher risk of breast 
cancer (Brody et al. 2007). In another pos­
sible gene–environment interaction, certain 
POPs may interact with CYP3A4, a critical 
enzyme for xenobiotic metabolism as well for 
endogenous/exogenous hormone metabolism 
that inhibits the metabolism of endogenous 
estradiol, thereby potentially increasing serum 
levels and increasing breast cancer risk through 
this mechanism (Hodgson and Rose 2007)
Heavy metals such as cadmium and lead 
are both known or probable carcinogens and 
also have estrogenic properties (Choe et al. 
2003). Lead exposure has been associated with 
later pubertal onset or menarche in several 
studies (Denham et al. 2005; Selevan et al. 
2003; Wu et al. 2003), but both lead and 
cadmium have been associated with increased 
breast cancer risk in human epidemiologic 
studies (Cantor et al. 1995; McElroy et al. 
2006). Environmental tobacco smoke (ETS) 
has been assessed in girls and is associated 
with early menarche (Reynolds et al. 2004; 
Windham et al. 2004). However, mechanisms 
by which ETS might contribute to earlier 
menarche remain to be elucidated, especially 
by examining possible gene–environment 
interactions such as those with NAT2 slow 
acetylator and GSTMI null genotypes that 
may be associated with breast cancer in adults 
(Ambrosone et al. 2008).
Polycyclic aromatic hydrocarbons (PAHs) 
are a large class of chemicals formed by the 
incomplete combustion of coal, oil, and gas, 
as well as tobacco smoke and other substances 
to which humans are exposed in ambient air. 
These substances are genotoxic and known to 
be potential breast carcinogens (Morris and 
Seifter 1992), perhaps by damaging DNA 
through oxidative stress. Animal experiments 
indicate that puberty and early development 
may be the period during which the breast is 
most sensitive to these effects (Fenton 2006). 
In addition, because air pollution can vary by 
neighborhood environments, there may be 
an interaction between PAH exposure and 
the social environment (Morello­Frosch and 
Jesdale 2006).
One of the most commonly voiced cancer­
related public concerns is the possible impact 
of hormones in food, because U.S. animal 
food sources are frequently exposed to growth 
hormones to boost production of meat, dairy 
products, and eggs. Because higher levels of 
estradiol may induce the hypothalamic burst 
of gonadotropin that initiates puberty, the 
impact of hormone­treated cattle deserves 
further study (Massart et al. 2006). In the 
BCERC studies, questions are being directed 
to the consumption of organic food consump­
tion as an indirect measure of such exposures.
Finally, among environmental factors, ion­
izing radiation exposure has long been rec­
ognized as a risk factor for breast cancer in 
humans, probably as a result of the induction 
of DNA double­strand breaks. An increased 
risk of breast cancer has been consistently 
reported for radiation exposure from various 
sources, including the atomic weapon explo­
sions in Nagasaki­Hiroshima (Tokunaga 
et al. 1991), and medical treatments for a 
large number of conditions (Boice et al. 1991; 
John and Kelsey 1993; Shore et al. 1993), 
and among radiologic technologists (Boice 
et al. 1995). Among atomic bomb survi­
vors, increased risk has been related clearly to 
younger age at exposure (Land et al. 2003). 
Elevated breast cancer risk in areas with rela­
tively lose doses of radiation contamination 
from the Chernobyl accident has been noted 
in Belarus (average cumulative dose ≥ 40 mSv) 
about 10 years after the incident, and risk was 
greater among women younger at exposure 
(Pukkala et al. 2006). BCERC investigators 
are using radiation as a prototypical breast 
carcinogen to evaluate genetic and molecular 
mechanisms of carcinogenesis in rodent mod­
els, and we are assessing exposure by question­
naire in the epidemiology study.
For even the partial list of putative envi­
ronmental agents presented above, much 
remains to be elucidated, not only in terms 
of their biologic effects in animal models, but 
also the risks for adverse outcomes as assessed 
by human epidemiology. Furthermore, it is 
likely that chemicals interact with each other 
and that their individual effects are modified 
by the presence of genetic polymorphisms 
and by the social context in which the expo­
sure plays out. It is only with a prospective, 
longitudinal study with input from multi­
ple disciplinary perspectives, such as in the 
BCERC, that these effects and interactions 
can be illuminated.
The built environment. In addition to 
chemical toxicants in the physical environ­
ment, there are also aspects of the built envi­
ronment that can lead to childhood obesity 
and may contribute to earlier puberty and 
breast cancer incidence later in life.
For example, it is known that people who 
live in socioeconomically deprived neighbor­
hoods are more likely to be physically inac­
tive (Cubbin et al. 2006; Yen and Kaplan 
1998), to have less healthy dietary habits (Lee 
and Cubbin 2002), and to be obese (Cubbin 
et al. 2006). Socioeconomically deprived areas 
tend to have fewer food stores, more fast food 
stores, and more liquor stores (Morland et al. 
2002). In addition, economic and social meas­
ures and other macro­level elements, such as 
urban sprawl, have been associated with higher 
rates of obesity (Ewing et al. 2003). The urban 
design, planning, and transportation litera­
tures show that population density, connec­
tivity, and land­use mix are related in many 
studies to higher rates of walking and cycling 
for utilitarian purposes (Saelens et al. 2003). 
These factors may, in turn, be influenced by 
existing policies on land use, zoning, and other 
factors that impact the built environment. 
BCERC investigators will explore the relation­
ship of the built environment as determined 
both from interviews with caregivers as well as 
on­the­ground audits, in the Bay Area Center, 
of the characteristics of neighborhoods where 
the girls live. The audit observations will be 
linked to individual data from longitudinally 
obtained interviews with the girls.
The social environment. Childhood 
obesity is more prevalent in nonwhite and low­
income children, and thus factors associated 
with SES, race, and ethnicity could be con­
tributing to observed disparities in the onset 
of puberty. However, the relationship of SES 
and race/ethnicity to breast cancer is complex. 
Breast cancer is one of the few cancers related 
directly to higher SES and to being self­identi­
fied as white compared with black (above the 
age of about 40 years), Hispanic, and Asian 
women. Within race/ethnic groups, there is 
also a direct relationship with SES (Kelsey and 
Bernstein 1996). The most accepted explana­
tion for the direct positive relationship with 
SES is that higher­SES women tend to have 
their first child later in life, have fewer chil­
dren, and have menopause later, all of which 
raise the risk of breast cancer.
Until recently, the age of menarche has 
been lower in higher­SES populations and 
in more industrialized countries. In the last 
half­century, in the United States at least, this 
relationship may have changed. Epidemiologic 
evidence now suggests that lower SES is related 
to earlier puberty, as determined by entry into 
stage 2 breast development among girls in 
the United States (Ellis and Essex 2007). In 
one multiethnic cohort study, higher mater­
nal education predicted later menarche, but 
income was unrelated (Windham et al. 2004). 
The educational dimension of parental SES 
has also been associated with earlier puber­
tal development in other studies of predomi­
nantly white girls (Davison et al. 2003; Ellis 
and Essex 2007; Lee et al. 2007).
Although pathways linking SES and 
menarche activation are not well understood, 
it appears that body composition and nutri­
tion are essential parts of the puzzle (Lawson 
1999). These nutritional factors are likely to Hiatt et al.
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affect the endocrine milieu controlled by the 
HPG system, particularly endogenous estra­
diol and lower sex hormone–binding globulin 
(Vihko and Apter 1984). Multiple markers of 
social environment can alter these hormonal 
profiles at the time of mammary development 
and may explain disparity in menarchal age 
between black and white girls (McClintock 
et al. 2005). Because distributions of genetic 
polymorphisms vary by race/ethnicity, the 
influence of constitutional factors may also 
influence differences in age at puberty.
BCERC Organizational Structure
In addition to the four BCERCs described 
above, a coordinating center at the University 
of California, San Francisco (UCSF) site exists 
to coordinate questionnaire development, 
data entry, centralized data management, and 
pooled analyses. Bioinformatics support is being 
coordinated at the Fox Chase Cancer Center 
(Philadelphia, PA). Other aspects being coor­
dinated between centers include an Internet 
web site (http://www.bcerc.org), an intranet 
web site, and national meetings. A publications 
committee has developed and monitors proce­
dures for the analysis of pooled data, publica­
tion tracking, authorship protocols, ancillary 
studies, and other matters pertaining to pooled 
data and publications from the network.
Among the three centers that participate in 
the epidemiologic cohort study, UCSF (Kaiser 
Permanente), University of Cincinnati, and 
Fox Chase (Mount Sinai School of Medicine), 
there is a high degree of collaboration and 
standardization in the epidemiologic studies 
across centers to maximize opportunities for 
pooled analyses (i.e., increased sample size) 
and cross­site comparisons.
Integrated into the structure of the 
BCERCs are four COTCs. Members of the 
COTC include breast cancer advocates as well 
as academicians with expertise in communica­
tion. The primary role of the COTCs is the 
translation and dissemination of major research 
findings to the public through their member 
organizations. Specifically, the COTCs conduct 
their own research activities in communica­
tion and dissemination, develop fact sheets and 
other educational materials based on BCERC 
research, hold town hall meetings and other 
community activities, and assist with recruit­
ment and retention strategies for the epidemio­
logic study. Members participate on both the 
epidemiology and biology projects, disseminate 
educational information and scientific findings 
of the BCERC and ensure the inclusion of the 
community perspective in BCERC projects and 
facilitating the ongoing flow of information 
from the study team to the community and 
from the community back to the study team.
Specific results of constituent studies are 
being published from individual centers and 
collaborative efforts across centers. The reader 
is referred to the study Web site (www.bcerc.
org) for a listing of these publications to date 
(BCERC 2008).
Conclusion
The transdisciplinary nature of our approach 
derives first from the highly varied areas of 
expertise of the scientific team and the com­
munity partners. The disciplines represented 
include genetics, molecular and cell biol­
ogy, immunology, anatomy, radiation biol­
ogy, pediatrics, endocrinology, toxicology, 
nutritional sciences, communication science, 
and epidemiology. The BCERC investigators 
within the network are addressing specific 
research questions that focus on the common 
shared goal of the overall project: to under­
stand the role of the environment in pubertal 
development as a window on breast cancer 
etiology. The ongoing and integrated involve­
ment of community members and advocates 
in the research process and in communica­
tion with the public is a unique and effective 
way to advance the transdisciplinary science 
approach we have adopted.
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